120 related articles for article (PubMed ID: 25928918)
1. Survivin expression in canine lymphomas in relation with proliferative markers.
Sokołowska J; Urbańska K; Giziński S; Wysocka A; Cywińska A; Lechowski R
Pol J Vet Sci; 2015; 18(1):113-22. PubMed ID: 25928918
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression in correlation with apoptotic activity in canine lymphomas.
Sokołowska J; Urbańska K
Pol J Vet Sci; 2017 Mar; 20(2):329-338. PubMed ID: 28865215
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical assessment of metalloproteinases MMP2 and MMP9 expression in canine various subtypes of lymphomas in relation with proliferative and apoptotic markers.
Sokołowska J; Urbańska K
Pol J Vet Sci; 2019 Jun; 22(2):203-211. PubMed ID: 31269334
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma.
Rebhun RB; Lana SE; Ehrhart EJ; Charles JB; Thamm DH
J Vet Intern Med; 2008; 22(4):989-95. PubMed ID: 18647159
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of P-glycoprotein in various subtypes of canine lymphomas.
Sokołowska J; Urbańska K; Giziński S; Zabielska K; Lechowski R
Pol J Vet Sci; 2015; 18(1):123-30. PubMed ID: 25928919
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in canine epidermis and in canine and human cutaneous squamous cell carcinomas.
Bongiovanni L; Colombi I; Fortunato C; Della Salda L
Vet Dermatol; 2009 Oct; 20(5-6):369-76. PubMed ID: 20178473
[TBL] [Abstract][Full Text] [Related]
7. Variation of apoptotic and proliferative activity among lymphoma subtypes in dogs: A flow cytometric study.
Riondato F; Martini V; Melega M; Poggi A; Miniscalco B
Res Vet Sci; 2021 Mar; 135():324-328. PubMed ID: 33779558
[TBL] [Abstract][Full Text] [Related]
8. Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma.
Shoeneman JK; Ehrhart EJ; Charles JB; Thamm DH
Vet Comp Oncol; 2016 Jun; 14(2):e45-57. PubMed ID: 24923332
[TBL] [Abstract][Full Text] [Related]
9. Proliferation activity in canine lymphomas.
Sokołowska J; Micun J; Malicka E; Lechowski R
Pol J Vet Sci; 2012; 15(4):727-34. PubMed ID: 23390763
[TBL] [Abstract][Full Text] [Related]
10. Mismatch between transcriptomic and histopathologic picture of canine lymphomas.
Ostrzeszewicz M; Maciejewski H; Sapierzyński R; Micuń J; Majewska A; Lechowski R; Motyl T; Jank M
Pol J Vet Sci; 2012; 15(4):781-90. PubMed ID: 23390770
[TBL] [Abstract][Full Text] [Related]
11. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
12. Study of DNA topoisomerase IIa expression in canine lymphomas and its potential role as a marker of sensitivity to anthracycline-based chemotherapy in dogs.
Klimiuk P; Lopuszynski W; Bulak K; Smiech A; Brzana A
Folia Histochem Cytobiol; 2020; 58(1):46-53. PubMed ID: 32176312
[TBL] [Abstract][Full Text] [Related]
13. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.
Carter RF; Valli VE; Lumsden JH
Can J Vet Res; 1986 Apr; 50(2):154-64. PubMed ID: 3756669
[TBL] [Abstract][Full Text] [Related]
14. Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions.
Bongiovanni L; Suter MM; Malatesta D; Ordinelli A; Ciccarelli A; Romanucci M; Brenner O; Della Salda L
Vet Dermatol; 2012 Oct; 23(5):394-e73. PubMed ID: 22681570
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of cyclooxygenase-2 in normal, hyperplastic and neoplastic canine lymphoid tissues.
Asproni P; Vignoli M; Cancedda S; Millanta F; Terragni R; Poli A
J Comp Pathol; 2014 Jul; 151(1):35-41. PubMed ID: 24813155
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of survivin in canine lymphoma.
Wimmershoff J; Polkinghorne A; Grest P; Schade B; Marchal T; Keller SM; Guscetti F
J Comp Pathol; 2010 May; 142(4):311-22. PubMed ID: 20116802
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.
Bongiovanni L; Mazzocchetti F; Malatesta D; Romanucci M; Ciccarelli A; Buracco P; De Maria R; Palmieri C; Martano M; Morello E; Maniscalco L; Della Salda L
BMC Vet Res; 2012 Jun; 8():78. PubMed ID: 22686277
[TBL] [Abstract][Full Text] [Related]
18. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
19. Survivin and Sox9: Potential Stem Cell Markers in Canine Normal, Hyperplastic, and Neoplastic Canine Prostate.
Bongiovanni L; Caposano F; Romanucci M; Grieco V; Malatesta D; Brachelente C; Massimini M; Benazzi C; Thomas RE; Salda LD
Vet Pathol; 2019 Mar; 56(2):200-207. PubMed ID: 30131013
[TBL] [Abstract][Full Text] [Related]
20. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
